On Thursday, Merck & Co Inc (NYSE: MRK) topped estimates with its fourth quarter revenue and adjusted earnings fueled by its blockbuster cancer drug Keytruda, along with HPV prevention vaccine Gardasil. However, Merck still recorded a net quarterly loss due to charges that resulted from a
U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.25% to 38,618.79 while the NASDAQ rose 0.34% to 15,661.70. The S&P 500 also rose, gaining, 0.34% to 4,971.18.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Pablo Zuanic, senior analyst at Zuanic & Associates delves into Canada's cannabis vape market, looking at its diversity and growth driven by evolving consumer preferences and regulatory shifts.
Shares of Fortinet, Inc. (NASDAQ: FTNT) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued guidance.